Cargando…

Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays

BACKGROUND: Multiple myeloma (MM) is characterized by a strong dependence of the tumor cells on their microenvironment, which produces growth factors supporting survival and proliferation of myeloma cells (MMC). In the past few years, many myeloma growth factors (MGF) have been described in the lite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahtouk, Karène, Moreaux, Jérôme, Hose, Dirk, Rème, Thierry, Meißner, Tobias, Jourdan, Michel, Rossi, Jean François, Pals, Steven T, Goldschmidt, Hartmut, Klein, Bernard
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882921/ https://www.ncbi.nlm.nih.gov/pubmed/20465808 http://dx.doi.org/10.1186/1471-2407-10-198

Ejemplares similares

A new method for class prediction based on signed-rank algorithms applied to Affymetrix(® )microarray experiments
por: Rème, Thierry, et al.
Publicado: (2008)

Identification of Pluripotent and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor Prognosis in Multiple Myeloma
por: Kassambara, Alboukadel, et al.
Publicado: (2012)

Inhibition of DEPDC1A, a Bad Prognostic Marker in Multiple Myeloma, Delays Growth and Induces Mature Plasma Cell Markers in Malignant Plasma Cells
por: Kassambara, Alboukadel, et al.
Publicado: (2013)

A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy
por: Kassambara, Alboukadel, et al.
Publicado: (2014)

Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma
por: Viziteu, Elena, et al.
Publicado: (2016)

Drug metabolism and clearance system in tumor cells of patients with multiple myeloma
por: Hassen, Wafa, et al.
Publicado: (2014)

Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors
por: Moreaux, J, et al.
Publicado: (2013)

CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma
por: Alaterre, Elina, et al.
Publicado: (2017)

Transcriptional Silencing of the Wnt-Antagonist DKK1 by Promoter Methylation Is Associated with Enhanced Wnt Signaling in Advanced Multiple Myeloma
por: Kocemba, Kinga A., et al.
Publicado: (2012)

Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1
por: Wagner, Verena, et al.
Publicado: (2014)

miRNAs in multiple myeloma – a survival relevant complex regulator of gene expression
por: Seckinger, Anja, et al.
Publicado: (2015)

Combining Affymetrix microarray results
por: Stevens, John R, et al.
Publicado: (2005)

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells
por: Bruyer, Angelique, et al.
Publicado: (2018)

GenomicScape: An Easy-to-Use Web Tool for Gene Expression Data Analysis. Application to Investigate the Molecular Events in the Differentiation of B Cells into Plasma Cells
por: Kassambara, Alboukadel, et al.
Publicado: (2015)

Sources of variation in Affymetrix microarray experiments
por: Zakharkin, Stanislav O, et al.
Publicado: (2005)

Assessing affymetrix GeneChip microarray quality
por: McCall, Matthew N, et al.
Publicado: (2011)

Computational method for reducing variance with Affymetrix microarrays
por: Welle, Stephen, et al.
Publicado: (2002)

Equalizer reduces SNP bias in Affymetrix microarrays
por: Quigley, David
Publicado: (2015)

Celsius: a community resource for Affymetrix microarray data
por: Day, Allen, et al.
Publicado: (2007)

Analysis of probe level patterns in Affymetrix microarray data
por: Cambon, Alexander C, et al.
Publicado: (2007)

Reproducibility of gene expression across generations of Affymetrix microarrays
por: Nimgaonkar, Ashish, et al.
Publicado: (2003)

Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study
por: Rossi, J-F, et al.
Publicado: (2009)

PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs
por: Herviou, Laurie, et al.
Publicado: (2018)

SULFs in human neoplasia: implication as progression and prognosis factors
por: Bret, Caroline, et al.
Publicado: (2011)

Meta-Analysis Combines Affymetrix Microarray Results Across Laboratories
por: Stevens, John R., et al.
Publicado: (2005)

Methods for evaluating gene expression from Affymetrix microarray datasets
por: Jiang, Ning, et al.
Publicado: (2008)

Towards the uniform distribution of null P values on Affymetrix microarrays
por: Fodor, Anthony A, et al.
Publicado: (2007)

G-spots cause incorrect expression measurement in Affymetrix microarrays
por: Upton, Graham JG, et al.
Publicado: (2008)

Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial
por: Hose, Dirk, et al.
Publicado: (2019)

Kinome expression profiling to target new therapeutic avenues in multiple myeloma
por: de Boussac, Hugues, et al.
Publicado: (2020)

In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma
por: Maes, Ken, et al.
Publicado: (2014)

Validation and extension of an empirical Bayes method for SNP calling on Affymetrix microarrays
por: Lin, Shin, et al.
Publicado: (2008)

Microarray labeling extension values: laboratory signatures for Affymetrix GeneChips
por: Lee, Yun-Shien, et al.
Publicado: (2009)

PLANdbAffy: probe-level annotation database for Affymetrix expression microarrays
por: Nurtdinov, Ramil N., et al.
Publicado: (2010)

An end to end workflow for differential gene expression using Affymetrix microarrays
por: Klaus, Bernd, et al.
Publicado: (2018)

Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance
por: Vikova, Veronika, et al.
Publicado: (2019)

Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells
por: Meißner, Tobias, et al.
Publicado: (2015)

MAAMD: a workflow to standardize meta-analyses and comparison of affymetrix microarray data
por: Gan, Zhuohui, et al.
Publicado: (2014)

Sources of High Variance between Probe Signals in Affymetrix Short Oligonucleotide Microarrays
por: Jaksik, Roman, et al.
Publicado: (2013)

The Glycome of Normal and Malignant Plasma Cells
por: Moehler, Thomas M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1em4a90tij592pv5i1pvgv3fb8